Company: PETVW
Filing Date: 2025-07-10
Form Type: 10-K
Source: 0001641172-25-018617
Chunk: 436

Company: PetVivo Holdings, Inc.
Filing Date: 2025-07-10
Form: 10-K
Item: Item 2
Chunk 436
---
 Total operating expenses

    9,050,575

    11,488,223

    NET OPERATING LOSS

    (8,055,720
    )

    (10,621,340
    )

NOTE
17 – SUBSEQUENT EVENTS

On April 1, 2025, the Company issued 52,500 shares
related to vesting of restricted stock units (“RSUs”).

From April 3, 2025 to July 10, 2025, the Company issued
a total of 68,000 shares to service providers for consulting services with a fair value on the date of grant of $46,420.

On June 6, 2025, the Company issued 70,000 shares
related to a warrant exercise with proceeds of $140,000.

On June 10, 2025, the Company entered
into a short-term convertible promissory note with an accredited investor for $160,000
with an annual interest rate of 10%
and a maturity date of December
31, 2025. The principal amount and all accrued interest of the
convertible note may be converted to shares of common stock (“Shares”) at a conversion price of $0.75 per Share. The Company also issued 75,000 warrants, with a strike price of $0.75, a term of 2 years and a relative fair value of approximately
$20,000, which will be reflected as a discount to the convertible note.

In May and June 2025, the Company received $4,400,000
in connection with the Series B Preferred Stock subscription receivable.

In May and June 2025, three of the
Company Directors collectively entered into three short-term notes in an aggregate amount of $12,000 
with an annual interest rate of 10%
and a maturity date that is the earlier of December
31, 2025, or the closing of our Series B Preferred round.

On
June 10, 2025, the Company issued 225,000 warrants to two consultants, with a strike price of $0.75, having a 3three-year term and fair
valued at $68,363, which will be expensed over thirty-six months.

In
June 2025, a warrant holder exercised 70,000 warrants with a strike price of $2.00 per share resulting in $140,000 proceeds to the Company.
As an inducement to have the warrant